Alkame Water Secures Southern California Distributor

LAS VEGAS, NV--(Marketwired - Jan 13, 2014) - Alkame Holdings, Inc. (OTCBB: PINSD) (OTCQB: PINSD), a health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products, is pleased to announce that the Company has entered into an agreement with Avanzar Sales and Distribution, LLC., a California-based beverage focused distribution and consulting company.

"We are extremely pleased to have partnered with Avanzar as our exclusive distributor in Southern California," stated Robert Eakle, CEO of Alkame Holdings, Inc. "In addition to having access to a potential direct retail footprint of over 7,000 stores in Southern California, we are most excited about the possibility of leveraging Avanzar's capabilities as a national beverage brand distribution builder."

Headquartered in Brea, California, Avanzar Sales and Distribution is a world-class brand incubation house which specializes in working with early stage fast moving consumer goods brands to develop and implement sales and distribution strategies. Avanzar has a national representation reach and maintains a regional in-house Direct Store Delivery (DSD) operation servicing the Southern California marketplace. Avanzar provides brand owners with actionable, results-oriented solutions and services that assist in delivering their products to the marketplace. Avanzar distributes products to some of the most trusted retailers in the United States, including Kroger, Walgreens, 7-Eleven, Kmart, Winco, Safeway, Whole Foods, Sprouts, HEB, and Albertsons. 

"When Alkame Water says that 'Not All Waters are Created Equally' they aren't just referring to their patented processes or their trifecta of superior functionality. They are also referring to supply chain profitability," stated Bill Juarez, President of Avanzar Sales and Distribution. "We are eager to get started using our previous experiences with high end water brands Voss and Volvic to turn Alkame Water into the leading premium functional water brand in the Western U.S. and beyond."

Mr. Eakle concluded, "With Avanzar's brand building and distribution assistance, Alkame will be able to more quickly rollout an effective overall sales strategy and to identify potential distribution and brokerage partners throughout the United States. I look forward to establishing the Alkame brand footprint in new territories across the country."

About Alkame Holdings, Inc.

Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame's patented technology creates water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. The patented Alkame technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function. Not all waters are created equal™. For more information, visit www.alkamewater.com. 

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.